JY231

BIOLOGICAL2 trials

Sponsors

Shanxi Bethune Hospital, 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China

Conditions

Autoimmune DiseasesB-cell Acute Lymphoblastic Leukemia (B-ALL)

Early Phase 1

JY231(Internal Clinical Drug Code) Injection for the Treatment of Refractory Autoimmune Diseases

Not yet recruitingNCT06243159

Shanxi Bethune HospitalAutoimmune Diseases

Start: 2024-02-08End: 2026-12-31Target: 20Updated: 2024-02-06

JY231 (JY231) Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia (B-ALL)

RecruitingNCT06514768

920th Hospital of Joint Logistics Support Force of People's Liberation Army of ChinaB-cell Acute Lymphoblastic Leukemia (B-ALL)

Start: 2024-06-20End: 2026-06-30Target: 20Updated: 2026-01-06